These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8907837)

  • 1. Chronic inflammatory demyelinating polyneuropathy.
    Smith H; Salam I; Findley LJ
    J R Army Med Corps; 1994 Jun; 140(2):90-2. PubMed ID: 8907837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy in the inflammatory neuropathies.
    Churchyard A; Day T; Grainger K; Mastaglia FL
    Clin Exp Neurol; 1991; 28():168-79. PubMed ID: 1821824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An "n of 1" trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.
    Hankey GJ; Todd AA; Yap PL; Warlow CP
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1137. PubMed ID: 8089690
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
    Gorson KC; Allam G; Ropper AH
    Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy of chronic inflammatory demyelinating polyneuropathy].
    Lünemann JD; Prass K; Zschenderlein R
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):672-8. PubMed ID: 15580532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
    van Schaik IN; Vermeulen M; van Doorn PA; Brand A
    J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments.
    Nemni R; Amadio S; Fazio R; Galardi G; Previtali S; Comi G
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):43-5. PubMed ID: 7964852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy.
    Currò Dossi B; Tezzon F
    Ital J Neurol Sci; 1987 Aug; 8(4):321-6. PubMed ID: 3119516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyneuropathy.
    Briani C; Brannagan TH; Trojaborg W; Latov N
    Neuromuscul Disord; 1996 Oct; 6(5):311-25. PubMed ID: 8938696
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
    Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
    No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute demyelinating polyneuropathy induced by nivolumab.
    Fukumoto Y; Kuwahara M; Kawai S; Nakahama K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):435-437. PubMed ID: 28844069
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a.
    Gorson KC; Ropper AH; Clark BD; Dew RB; Simovic D; Allam G
    Neurology; 1998 Jan; 50(1):84-7. PubMed ID: 9443462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of demyelinating polyneuropathies of different origins with small doses of immunoglobulin G].
    Popova LM; Avdiunina IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(5):27-9. PubMed ID: 9245154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy.
    Zinman LH; Sutton D; Ng E; Nwe P; Ngo M; Bril V
    Transfus Apher Sci; 2005 Nov; 33(3):317-24. PubMed ID: 16239123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.
    Dimachkie MM; Barohn RJ; Katz J
    Neurol Clin; 2013 May; 31(2):533-55. PubMed ID: 23642723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy.
    Small GA; Lovelace RE
    Semin Neurol; 1993 Sep; 13(3):305-12. PubMed ID: 8272603
    [No Abstract]   [Full Text] [Related]  

  • 19. [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Kusunoki S
    Nihon Naika Gakkai Zasshi; 2013 Aug; 102(8):1965-70. PubMed ID: 24167855
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.
    van Doorn PA; Brand A; Strengers PF; Meulstee J; Vermeulen M
    Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.